[1]
M. Sulaiman, D. et al. 2017. Efficacy, safety and Cardiovascular Disease Risk Lowering Ability of ACE Inhibitors, B-Blockers and Combination Antihypertensive Drug Regimes in Iraq. Iraqi Journal of Pharmaceutical Sciences. 22, 1 (Mar. 2017), 5–17. DOI:https://doi.org/10.31351/vol22iss1pp5-17.